Topic
340B
257 published works
Duane Morris Health Law
340B Hospital Reimbursement Update: D.C. District Court Remands Underpayment Remedy to HHS
By Duane Morris
On Tuesday, January 10, 2023, the United States District Court for the District of Columbia issued an important ruling allowing the U.S. Department of Health and Human Services (HHS) to…
Medicaid & Medicare: A Legal Blog
340B Drug Pricing Program: Drug Companies Are Concerned!
The federal 340B Drug Pricing Program allows qualifying hospitals and clinics that treat low-income and uninsured patients to buy outpatient prescription drugs at a discount of 25 percent to 50 percent.…
Health Law Update
Discounted Drugs under the 340B Program
By Lee H. Rosebush, Laura Macherelli, Marc Wagner
The U.S. Court of Appeals for the Third Circuit is currently hearing arguments from pharmaceutical manufacturers Novo Nordisk, Sanofi and AstraZeneca and the Department of Health and Human Services (HHS)…
To Be or Not to 340B Blog
Brenda Shafer, Michael French and Richard Davis Author <em>Law360</em> Article on Questions Related to Section 340B Drug Pricing
By Brenda Maloney Shafer, Michael French, Richard Davis
Quarles Health & Life Sciences attorneys Brenda Shafer, Michael French and Richard Davis recently wrote an article for Law360 about questions surrounding the ability of the Health Resources and Services Administration’s ability…
Healthcare Perspectives
CMS Issues OPPS/ASC Payment System Final Rule and Physician Fee Schedule Final Rule
By Paul L. Croce, John W. Kaveney, James A. Robertson
On November 1, 2022, the Centers for Medicare & Medicaid Services (CMS) issued two important final rules: one that included updates and policy changes for Medicare payments under the Physician…
To Be or Not to 340B Blog
340B Program Changes on the Horizon? Start Planning Now for Potentially Seismic Impact of Upcoming Genesis Decision
By Michael French, Brenda Maloney Shafer, Richard Davis
As the extensively covered Genesis Healthcare, Inc. v. Azar case continues to proceed, 340B covered entities expect to soon receive much-anticipated clarification on what can reasonably constitute a 340B eligible patient. In…
Health Law Diagnosis
340B Update: District Court Rejects 2022 Payment Methodology for 340B Hospitals Following Supreme Court Win
By Robinson+Cole's Health Law Group
We follow up on our previous blog post concerning the U.S. Supreme Court’s unanimous ruling in favor of 340B hospitals. The Supreme Court previously held that “absent a survey of…
Medicaid and the Law
HHS Ordered to Correct Medicare Payments to 340B Hospitals for Remainder of 2022
We have noted before the link between the Medicaid prescription drug rebate program and the 340B program. As we wrote in an earlier Client Alert, in June 2022, the U.S. Supreme…
Healthcare Perspectives
U.S. District Court Judge Vacates Unlawful Drug Reimbursement Rate For 340B Hospitals for Remainder of 2022
As we reported back in July on this blog, the U.S. Supreme Court earlier this year held that the federal government improperly lowered drug reimbursement payments to certain 340B hospitals…
Litigation Finance Journal
Adam Gerchen Discusses His Approach to Litigation Finance
By John Freund
Day 2 of the LF Dealmakers conference kicked off with Roy Strom, a reporter at Bloomberg Law, interviewing Adam Gerchen, CEO of Gerchen Keller Partners and Keller Postman LLP. Adam…